Alternatives to BeiGene

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

Clinical-stage biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) for cancer treatment.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Leveraging the adaptive immune system to diagnose and treat disease.

Developing engineered biologics to harness the immune system for disease treatment.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

AI-powered platform for personalized cell therapy development and manufacturing.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Biotechnology company developing novel immunotherapies for cancer.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Gene therapy company developing transformative treatments for severe genetic diseases.

Gene therapy company developing treatments for rare inherited diseases.

Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Biopharmaceutical company developing novel cancer therapies using targeted protein degradation.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

Global biopharmaceutical company focused on oncology, rare diseases, and neuroscience.

Global marketplace connecting researchers with human biospecimens for life science research.

Developing novel radiopharmaceuticals for targeted cancer treatment using advanced molecular imaging and therapy.

AI-powered spatial biology platform for precision medicine and drug development.

Develops novel therapeutic antibodies for oncology and autoimmune diseases.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

AI-powered platform for antibody discovery and development to create new medicines.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Biopharmaceutical company developing mRNA-based vaccines and therapeutics for infectious diseases and cancer.

Clinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A clinical-stage AI drug discovery company accelerating the development of novel therapeutics for various diseases.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.

A biotechnology company developing genetic therapies for rare disorders.

A global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for patients with serious diseases.

AI-powered platform accelerating biological research and drug discovery.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Develops advanced gene editing and cell therapy solutions for rare genetic diseases.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Developing oral small molecule medicines for immunological and chronic diseases.